🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PREMIERE parallel, non-comparative, two-arm, randomized 1:1, open-label, mu...
Status
Recruiting
Location
ICO Badalona
Start Date
2023-02-03
Trial ID
NCT05982093
Treatments Being Tested
RATIONALE: Studying samples of blood from patients with cancer in the labor...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2008-06-18
Trial ID
NCT00764322
A single 125 mg oral dose of the investigational compound PD-0332991 will b...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-04
Trial ID
NCT01821066
Treatments Being Tested
The PERCHE trial evaluated the worth of adding adjuvant chemotherapy for pr...
Status
Terminated
Location
National Institute of Oncology
Start Date
2003-08
Trial ID
NCT00066807
Treatments Being Tested
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
This is a Phase III, global, randomized, open-label, multicenter, study eva...
Status
Active Not Recruiting
Location
Southern Cancer Center
Start Date
2021-08-27
Trial ID
NCT04961996
Treatments Being Tested
Doctors leading this study would like to learn about providing cancer treat...
Status
Recruiting
Location
Lagos State University Teaching Hospital
Start Date
2025-03-18
Trial ID
NCT06348134
Treatments Being Tested
The purpose of this research project is to study the effect of a research (...
Status
Completed
Location
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
Start Date
2008-02-14
Trial ID
NCT00756717
Treatments Being Tested
MORE-T trial is designed to investigate the effect of Tamoxifen 40mg (vs. T...
Status
Active Not Recruiting
Location
Seoul National University Hospital
Start Date
2021-10-21
Trial ID
NCT04997941
Treatments Being Tested
CDK4/6 inhibitors are currently the standard treatment for female breast ca...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2023-05-15
Trial ID
NCT05861830